Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
HHS lifts stop work order on Vaxart's COVID-19 trial
*please scroll down for all the latest news *
